The 340B Drug Pricing Program has been an essential resource for hospitals and health centers serving underserved communities, but the landscape is evolving. As manufacturers tighten restrictions and the program faces increasing scrutiny, it’s crucial for covered entities to stay informed and adapt to these changes. Let’s explore the current state of the 340B program and what the future may hold for healthcare providers and patients.
Read More: https://340bwell.com/case-studies/the-future-of-the-340b-drug-pricing-p…